125 related articles for article (PubMed ID: 2839218)
1. Reduction or loss of HLA-A,B,C antigens in colorectal carcinoma appears not to influence survival.
Stein B; Momburg F; Schwarz V; Schlag P; Moldenhauer G; Möller P
Br J Cancer; 1988 Apr; 57(4):364-8. PubMed ID: 2839218
[TBL] [Abstract][Full Text] [Related]
2. HLA antigens in colorectal tumours--low expression of HLA class I antigens in mucinous colorectal carcinomas.
van den Ingh HF; Ruiter DJ; Griffioen G; van Muijen GN; Ferrone S
Br J Cancer; 1987 Feb; 55(2):125-30. PubMed ID: 3028461
[TBL] [Abstract][Full Text] [Related]
3. Loss of polymorphic A and B locus HLA antigens in colon carcinoma.
Rees RC; Buckle AM; Gelsthorpe K; James V; Potter CW; Rogers K; Jacob G
Br J Cancer; 1988 Apr; 57(4):374-7. PubMed ID: 3291922
[TBL] [Abstract][Full Text] [Related]
4. Loss of HLA-A,B,C in colorectal carcinoma is related to the degree of de-differentiation.
Momburg F; Möller P; Moldenhauer G; Hämmerling GJ
J Immunogenet; 1986; 13(2-3):195-9. PubMed ID: 3469275
[TBL] [Abstract][Full Text] [Related]
5. Selective loss of HLA-A,B,C locus products in colorectal adenocarcinoma.
Smith ME; Bodmer WF; Bodmer JG
Lancet; 1988 Apr; 1(8589):823-4. PubMed ID: 2895339
[No Abstract] [Full Text] [Related]
6. Loss of HLA-A,B,C and de novo expression of HLA-D in colorectal cancer.
Momburg F; Degener T; Bacchus E; Moldenhauer G; Hämmerling GJ; Möller P
Int J Cancer; 1986 Feb; 37(2):179-84. PubMed ID: 2417962
[TBL] [Abstract][Full Text] [Related]
7. Frequency of abnormal expression of HLA-A,B,C and HLA-DR molecules, invariant chain, and LFA-3 (CD58) in colorectal carcinoma and its impact on tumor recurrence.
Möller P; Koretz K; Schlag P; Momburg F
Int J Cancer Suppl; 1991; 6():155-62. PubMed ID: 1712347
[TBL] [Abstract][Full Text] [Related]
8. Influence of major histocompatibility complex class I and II antigens on survival in colorectal carcinoma.
Möller P; Momburg F; Koretz K; Moldenhauer G; Herfarth C; Otto HF; Hämmerling GJ; Schlag P
Cancer Res; 1991 Jan; 51(2):729-36. PubMed ID: 1985791
[TBL] [Abstract][Full Text] [Related]
9. MHC antigen expression in colorectal tumours.
Smith ME
Semin Cancer Biol; 1991 Feb; 2(1):17-21. PubMed ID: 1912514
[TBL] [Abstract][Full Text] [Related]
10. Regulation of HLA class I gene expression in human colorectal carcinoma.
Soong TW; Oei AA; Hui KM
Semin Cancer Biol; 1991 Feb; 2(1):23-33. PubMed ID: 1912515
[TBL] [Abstract][Full Text] [Related]
11. Expression of HLA-A,B,C antigens on primary and metastatic tumor cell populations of human carcinomas.
Cordon-Cardo C; Fuks Z; Drobnjak M; Moreno C; Eisenbach L; Feldman M
Cancer Res; 1991 Dec; 51(23 Pt 1):6372-80. PubMed ID: 1933900
[TBL] [Abstract][Full Text] [Related]
12. HLA class I gene expression on human primary tumours and autologous metastases: demonstration of selective losses of HLA antigens on colorectal, gastric and laryngeal carcinomas.
López-Nevot MA; Esteban F; Ferrón A; Gutiérrez J; Oliva MR; Romero C; Huelin C; Ruiz-Cabello F; Garrido F
Br J Cancer; 1989 Feb; 59(2):221-6. PubMed ID: 2649129
[TBL] [Abstract][Full Text] [Related]
13. Quantitation of MHC antigen expression on colorectal tumours and its association with tumour progression.
Durrant LG; Ballantyne KC; Armitage NC; Robins RA; Marksman R; Hardcastle JD; Baldwin RW
Br J Cancer; 1987 Oct; 56(4):425-32. PubMed ID: 3689659
[TBL] [Abstract][Full Text] [Related]
14. Loss of HLA-A,B,C allele products and lymphocyte function-associated antigen 3 in colorectal neoplasia.
Smith ME; Marsh SG; Bodmer JG; Gelsthorpe K; Bodmer WF
Proc Natl Acad Sci U S A; 1989 Jul; 86(14):5557-61. PubMed ID: 2473473
[TBL] [Abstract][Full Text] [Related]
15. Lithocholic acid inhibits the expression of HLA class I genes in colon adenocarcinoma cells. Differential effect on HLA-A, -B and -C loci.
Arvind P; Papavassiliou ED; Tsioulias GJ; Duceman BW; Lovelace CI; Geng W; Staiano-Coico L; Rigas B
Mol Immunol; 1994 Jun; 31(8):607-14. PubMed ID: 8196671
[TBL] [Abstract][Full Text] [Related]
16. HLA expression in human hepatocellular carcinoma.
Paterson AC; Sciot R; Kew MC; Callea F; Dusheiko GM; Desmet VJ
Br J Cancer; 1988 Apr; 57(4):369-73. PubMed ID: 2839219
[TBL] [Abstract][Full Text] [Related]
17. Tumor aggressiveness and MHC class I and II antigens in laryngeal and breast cancer.
Concha A; Esteban F; Cabrera T; Ruiz-Cabello F; Garrido F
Semin Cancer Biol; 1991 Feb; 2(1):47-54. PubMed ID: 1912518
[TBL] [Abstract][Full Text] [Related]
18. Loss of monomorphic and polymorphic HLA antigens in metastatic breast and colon carcinoma.
Goepel JR; Rees RC; Rogers K; Stoddard CJ; Thomas WE; Shepherd L
Br J Cancer; 1991 Nov; 64(5):880-3. PubMed ID: 1718386
[TBL] [Abstract][Full Text] [Related]
19. Anomolous expression of HLA-DR antigens on human colorectal cancer cells.
Daar AS; Fuggle SV; Ting A; Fabre JW
J Immunol; 1982 Aug; 129(2):447-9. PubMed ID: 6953153
[No Abstract] [Full Text] [Related]
20. Identification of locus-specific DNA-binding factors for the regulation of HLA class-I genes in human colorectal cancer.
Soong TW; Hui KM
Int J Cancer Suppl; 1991; 6():131-7. PubMed ID: 2066178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
